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Abstract
Background: Hemorrhagic shock (HS) is a major threat to patients with trauma and spontaneous bleeding. The
aim of the study was to investigate early effects of vasopressin on metabolic and hemodynamic parameters and
endothelium permeability by measuring capillary leakage compared to those of other resuscitation strategies in a
HS model.
Methods: Forty-five Sprague-Dawley rats were randomized into five groups: S group (n = 5), sham-operated rats
without shock or resuscitation; HS group (n = 10), HS and no resuscitation; RL group (n = 10), HS and resuscitation
with Ringer’s lactate (RL); RLB group (n = 10), HS and resuscitation with two-third shed blood plus RL; and
vasopressin group (n = 10), HS and resuscitation with RL, followed by continuous infusion of 0.04 U/kg/min
vasopressin. The effects of resuscitation on hemodynamic parameters [mean arterial pressure (MAP), superior
mesenteric artery blood flow (MBF), and mesenteric vascular resistances (MVR)], arterial blood gases, bicarbonate,
base deficit, and lactate levels as well as on capillary leakage in the lung, ileum, and kidney were investigated.
Capillary leakage was evaluated with Evans blue dye extravasation.
Results: In the vasopressin group, the MAP was higher than in the RL and RLB groups (p < 0.001), while MBF was
decreased (p < 0.001). MVR were increased only in the vasopressin group (p < 0.001). Capillary leakage was increased
in the lungs of the animals in the vasopressin group compared to that in the lungs of animals in the RLB group
(p < 0.05); this increase was associated with the lowest partial pressure of oxygen (p < 0.05). Conversely, decreased
capillary leakage was observed with vasopressin in the ileum (p < 0.05). Increased capillary leakage was observed in
the kidney in the RLB and vasopressin groups (p < 0.05). Lastly, vasopressin use was associated with higher base
deficit and lactate levels when compared to the RL and RLB groups (p < 0.001).
Conclusion: Although vasopressin was proposed as a vasoactive drug for provisional hemodynamic optimization in
the early phase of HS resuscitation, the overall findings of this experimental study focus on the possible critical side
effects of vasopressin on metabolic parameters and endothelium permeability.
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Background
Hemorrhagic shock (HS) represents a major threat to
trauma and spontaneous bleeding patients [1]. Organ
dysfunction and/or failure may be consequences of HS
and account for high mortality, despite adequate fluid
resuscitation and subsequent restoration of normoten-
sion. There is an ongoing discussion on strategies used
for resuscitation of trauma patients with HS [2]. Bleed-
ing control and maintenance of tissue oxygenation with
fluid resuscitation remain the mainstays of therapy for
patients with HS. However, severe and protracted
hypotension with decreased tissue perfusion induced by
an ongoing hemorrhage may progress in a condition of
profound shock, making the patient unresponsive to
fluid resuscitation and catecholamines. Correction of
hypovolemia does not resolve hypotension in these pa-
tients because of the occurrence of peripheral vasodilata-
tion. Landry and Oliver [3] suggested the following three
mechanisms that have been implicated in the pathogen-
esis of vasodilatory shock, which occurs during the late
phase of HS: (a) activation of ATP-sensitive potassium
channels in the plasma membrane of the vascular
smooth muscles, (b) activation of the inducible form of
nitric oxide synthase, and (c) deficiency of the hormone
vasopressin. The last mechanism led to the investigation
of the role of vasopressin in the treatment of advanced
stages of HS [4].
Recent animal studies have shown that vasopressin
treatment achieves hemodynamic optimization during the
early phase of HS (mimicking the prehospital phase) while
fluids and catecholamines showed neither improvement
of hemodynamic parameters nor survival [5, 6]. However,
vasopressin use has been associated with some adverse
effects such as ischemic complications particularly in the
splanchnic and skin circulation [7]. Moreover, a multicen-
ter prospective cohort study suggested that the early use
of vasopressors for hemodynamic improvement after HS
when compared to aggressive volume resuscitation was
deleterious and should be cautiously used, supporting the
concept of “caution before constriction” [8]. Collier et al.
found that vasopressin use was associated with increased
mortality in trauma patients with shock [9].
It has been demonstrated that intense inflammatory
response may develop after HS [10]. Massive blood loss
and resuscitation cause a global ischemia-reperfusion
effect with an upregulation of cytokine expression [11]
and oxidative and nitrosative stresses [12] that may lead to
organ damage and dysfunction. During advanced stages of
HS, changes in capillary permeability with leak and plasma
extravasation (i.e., capillary leakage) into the interstitial
space contribute to microcirculatory disturbances and
organ damage [13] with edema formation [14].
The aim of this study was to investigate the early
effects of vasopressin on metabolic and hemodynamic
parameters and endothelium permeability by measuring
capillary leakage compared to those of other resuscita-
tion strategies in a HS model.
Methods
Animal preparation and surgical procedure
All experiments were conducted in accordance with the
requirements indicated in the guidelines of Institutional
Animal Care and Use Committees (IACUC), after the
approval from the Ethics Committee of the Piedmont
Regulatory Agency for Care and Use of Laboratory Animals.
Male Sprague-Dawley rats (weight range, 290–350 g; me-
dian weight, 325 g; age range, 50–65 days) were used
(Charles River, Calco, Como, Italy). The animals were
housed individually and allowed free access to food and
water. The animal rooms were windowless with controlled
temperature (22 ± 2 °C) and lighting (12-h light/dark cycle),
where the rats were allowed to acclimatize for a minimum
of 5 days after arrival at the laboratory. Subsequently, the
animals were anesthetized with ketamine plus xylazine
intramuscular (90 and 10 mg/kg body weight [b.w.], re-
spectively) and restrained in a supine position. Body
temperature was monitored by a rectal thermal probe and
maintained at 37 °C with a heating pad. The left groin was
shaved and prepped with povidone-iodine solution. The
femoral artery was dissected using a minimal dissection
technique, distally ligated and cannulated with a 22-gauge
heparinized catheter. A blood pressure transducer (Isotec-
Healthdyne Cardiovascular, Marietta, GA) and a monitor
allowed for the continuous monitoring of mean arterial
pressure (MAP). A midline laparotomy was performed,
and superior mesenteric artery blood flow (MBF) was
measured with a perivascular probe (T206, Transonic
Systems, Ithaca, NY). Blood samples were collected
from the arterial catheter. Mesenteric vascular resis-
tances (MVR) were calculated as MAP/MBF. Arterial
blood gases, bicarbonate, base deficit, and lactate levels
were measured with a blood-gas analyzer (ABL System
500, Radiometer Medical, Copenhagen, Denmark).
Experimental protocol
Forty-five rats were randomized into the following five
groups: S group (n = 5), sham-operated (S) without
shock or resuscitation (anesthesia and artery cannulation
only); HS group (n = 10), HS and no resuscitation; RL
group (n = 10), HS and resuscitation with Ringer’s lactate
(RL) intravenously; RLB group (n = 10), HS and resuscita-
tion with two-third shed blood (i.e., 2/3 the hemorrhage
volume) plus RL; and vasopressin group (n = 10), HS and
resuscitation with RL, followed by continuous infusion of
0.04 U/kg/min vasopressin via a syringe pump (5 ml/h).
The experiment was carried out using a model with
pressure-controlled hemorrhage previously described [15]
(Fig. 1). Briefly, the experiment began by gradually bleeding
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each rat, except those in the S group, by withdrawing blood
from a catheter inserted into the femoral artery over a 10-
min period. The target value of HS was a reduction in
MAP to 35–40 mmHg. The constant MAP was main-
tained for 60 min with further withdrawal or infusion of
small amounts of shed blood. The blood was collected in a
heparinized tube and incubated at 37 °C. After 1 h of
shock, hemorrhaged rats, except those in the HS group,
were resuscitated with the same volume of fluids or shed
blood (11.3 ± 0.7 ml) over a 10-min period according to
the experimental protocol. Afterward, all the rats under-
went the same rate of fluid infusion (5 ml/h).
Monitoring after anesthesia recovery included attention
to specific criteria for evaluating the signs of postoperative
pain and distress. The rats were assessed clinically to judge
the efficacy of the analgesia, and an analgesic was adminis-
tered in the presence of behavioral signs of pain or distress
(rapid breathing, abnormal movement or posture/position-
ing, twitching/trembling) according to our institutionally
approved animal protocol developed through veterinary
consultation. Postoperative analgesia (ketamine, 80 mg/kg
b.w., intramuscular) was maintained throughout the ex-
perimental period until the animals were euthanized. In
relation to the type and duration of surgical procedure, no
animals showed any clinically apparent signs of pain or
distress with a single postoperative dose of ketamine.
Effects of resuscitation on capillary leakage in the lung,
ileum, and kidney were investigated in the three treat-
ment groups and compared to the HS group. Capillary
leakage was evaluated with Evans blue (EB) dye extrava-
sation using the following method: 1 h after the end of
resuscitation, 50 mg/kg b.w. of EB dye was injected as
previously described by Schumacher et al. [16]. Twenty
minutes after EB injection, the rats were euthanized with
an overdose of sodium pentobarbital (intravenously;
150 mg/kg b.w.). The inferior vena cava was incised to
exsanguinate the animals. An 18-gauge catheter was
placed into the apex of the left ventricle with its tip
inside the aorta in order to perfuse the circulatory sys-
tem with 0.9% NaCl containing heparin (100 U/ml). The































Fig. 1 Timeline experiment. Forty-five rats underwent anesthesia and artery cannulation. Forty rats were subjected to pressure-controlled
hemorrhage over a 10-min period, while five rats were sham-operated. The target value of hemorrhagic shock was a reduction in mean arterial
pressure (MAP) to 35–40 mmHg. The constant MAP was maintained for 60 min (shock period). After 1 h of shock, 30 hemorrhaged rats were
resuscitated over a 10-min period according to the experimental protocol. One hour after the end of resuscitation (observation period), Evans
blue dye was injected. Twenty minutes after Evans blue injection, all the rats were euthanized
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perfusion volume (at a perfusion pressure of 40 mmHg)
was four times the calculated blood volume of rat
(7.46 ml/100 g b.w.). This procedure allows the removal
of excess intravascular dye following which the lungs,
kidneys, and ileum were dissected and removed. The
tissues were rinsed in saline, gently blotted, and weighed.
Half of each tissue was dried by incubation at 60 °C for
48 h. EB was extracted from the remaining halves by in-
cubation in formamide (4 ml/g tissue; 99.5%, F-7503,
Sigma Aldrich Chemie, Germany) at room temperature
for 48 h. The supernatant was removed from the tissues
and read against a formamide blank at 620 nm
(Spectrophotometer, Beckmann DU 7400, Germany).
Absorbance was compared to a standard curve of
0.05–50 μg ml−1 EB in formamide. Extravasation was
expressed as microgram EB per gram dry tissue. The
blood samples and parameters (MAP, MBF, and MVR)
were obtained at 0′ (at the start of the experiment),
10′ (end of shock period), and 140′ (at 1 h after the
end of resuscitation). The collection of blood samples
(hemoglobin, partial pressure of oxygen, bicarbonates,
base deficit, and lactate) and tissue specimens (lung,
ileum, and kidney) in the S and HS groups was time-
matched to the resuscitation groups.
Statistical analysis
The hemodynamic and metabolic variables were expressed
as mean ± standard deviation. Multiple comparisons
between groups of parametric data were carried out
using one-way ANOVA, followed by the Bonferroni
post hoc test. The level of significance was defined as
a p value < 0.05. Data were analyzed by R 3.3.2 (R




The amount of shed blood was 8.0 ± 0.7 ml (26 ± 3.1 ml/kg
b.w.); no differences in total blood loss were observed be-
tween the groups. MAP decreased from 105 ± 10 to 40 ±
4 mmHg after blood withdrawal (10′) in the hemorrhaged
rats. At 140′, the MAP was higher in the vasopressin group
than in the RL and RLB groups (102 ± 12.9, 55.5 ± 8.0, and
68.5 ± 10.3 mmHg, respectively, p < 0.001) (Fig. 2a).
At 10′, there were no differences in MBF among the
hemorrhaged groups. At 140′, the MBF was higher in
the RL and RLB groups when compared to the vasopres-
sin group (4.5 ± 0.5, 5.2 ± 0.6, and 2.7 ± 0.3 ml/min,
respectively, p < 0.001) (Fig. 2b).
At 10′, no differences in MVR (i.e., MAB/MBF)
among the hemorrhaged groups were noted. At 140′,
the MVR were increased only in the vasopressin group
(34.5 ± 4.2 mmHg ml−1 min, p < 0.001) and remained
unmodified in the RLB (13.1 ± 1.0 mmHg ml−1 min)
and RL groups (12.4 ± 1.4 mmHg ml−1 min) (Fig. 2c).
No mortality occurred during the experimental period.
Laboratory data
Hemoglobin was decreased after hemorrhage and par-
tially recovered at 140′ only in the RLB group (p < 0.05)
(Fig. 3a). Likewise, the partial pressure of oxygen (pO2)
was partially recovered at 140′ in the RLB group only
(p < 0.05). The pO2 was significantly lowest in the
vasopressin group when compared to the other groups
(p < 0.05) (Fig. 3b).
At 10′, bicarbonate levels were decreased in all the groups
(Fig. 4a), while base deficit (Fig. 4b) and lactate levels (Fig. 4c)




Fig. 2 Hemodynamic parameters. Data are represented as
mean ± SD of mean arterial pressure (MAP) expressed as mmHg (a),
mesenteric arterial blood flow (MBF) expressed as milliliters per
minute (b), and MAP/MBF ratio (mmHg ml−1 min) (c). S, sham-operated;
HS, hemorrhagic shock; RL, resuscitation with Ringer’s lactate; RLB,
resuscitation with Ringer’s lactate and blood; AVP, resuscitation with
Ringer’s lactate and vasopressin infusion. a ***p< 0.001 AVP vs RL and
RLB; b ***p< 0.001 RL and RLB vs AVP; c ***p< 0.001 AVP vs all
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persistently decreased in the HS, RL, and RLB groups
(p < 0.01), and the vasopressin group (p < 0.001). A
significant increase in base deficit was observed in the
vasopressin group at 140′ when compared to the RL and
RLB groups (p < 0.001). Furthermore, lactate levels were
higher in the vasopressin group when compared to the RL
and RLB groups at 140′ (p < 0.001).
Capillary leakage
Capillary leakage, evaluated as EB extravasation, was in-
creased in the lung, ileum, and kidney in the HS group
when compared to the S group (p < 0.05). In the
lung, increased capillary leakage was observed in the
RLB group when compared to the HS and RL groups
(p < 0.05) and in the vasopressin group when com-
pared to the HS and RL (p < 0.01) and RLB (p < 0.05)
groups (Fig. 5a). In the ileum, increased capillary leakage
was noted in the RLB group (p < 0.05) when compared to
the HS and RL groups, whereas in the vasopressin group,
the leakage was decreased when compared to the HS and
RL (p < 0.05) and RLB (p < 0.01) groups (Fig. 5b). In-
creased capillary leakage was observed in the kidney in
the RLB and vasopressin groups when compared to the
HS and RL groups (p < 0.05) (Fig. 5c).
Discussion
Bleeding control, maintenance of tissue oxygenation with
fluid resuscitation, coagulation support, and maintenance
of normothermia remain the mainstays of therapy for pa-
tients with HS [2]. Maintenance of adequate perfusion
pressure assists tissue oxygenation and reduces the risk of
short- and long-term organ failure and sepsis. This practice
has been challenged in both clinical trials and experimental
a
b
Fig. 3 Hemoglobin and partial pressure of oxygen. Data are
represented as mean ± SD of hemoglobin (Hb) concentration
expressed as milligrams per liter (a) and partial pressure of oxygen
(pO2) expressed as mmHg (b). S, sham-operated; HS, hemorrhagic
shock; RL, resuscitation with Ringer’s lactate; RLB, resuscitation with
Ringer’s lactate and blood; AVP, resuscitation with Ringer’s lactate
and vasopressin infusion. a *p < 0.05 RLB vs HS, RL, and AVP;




Fig. 4 Bicarbonates, base deficit, and lactate. Data are represented as
mean ± SD of bicarbonate (HCO3
−) levels expressed as milliequivalents
per liter (a), base deficit (BD) levels expressed as mEq/l (b), and lactate
levels expressed as millimoles per liter (c). S, sham-operated; HS,
hemorrhagic shock; RL, resuscitation with Ringer’s lactate; RLB,
resuscitation with Ringer’s lactate and blood; AVP, resuscitation with
Ringer’s lactate and vasopressin infusion. a ***p < 0.001 S vs all at 10′,
**p < 0.01 HS, RL, and RLB vs S at 140′, ***p < 0.001 AVP vs all at 140′; b
***p < 0.001 S vs all at 10′, ***p < 0.001 AVP vs all at 140′; c ***p < 0.001
S vs all at 10′, ***p < 0.001 AVP vs all at 140′
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models [17, 18]. After trauma, fluid infusion of large-
volume normal saline or small-volume hypertonic saline
solutions may result in side effects, such as tissue edema
and re-bleeding with hemodynamic deterioration and in-
creased mortality [19, 20].
The use of a vasopressor in case of vasodilatation or
insufficient vasoconstriction is effective in restoring the
hemodynamic parameters with adequate vital organ
infusion, thereby reducing the need for continuous fluid
infusion [21, 22]. Indeed, previous studies demonstrated
increased survival when a small-volume fluid hypotensive
resuscitation concept was used for penetrating trauma
[23]. Several vasopressors including vasopressin have been
studied in HS. Vasopressin acts via a number of receptors
that are different from those of catecholamines. It exerts a
direct vasoconstrictor effect on the systemic vascular
smooth muscle by means of the vasopressin V1 receptors.
In our study, MAP was restored to baseline values only
in the vasopressin group; administration of RL solution
with or without blood did not obtain this effect. In the
vasopressin group, we observed consistent vasoconstric-
tion of the sub-diaphragmatic vascular bed, as demon-
strated by the absence of improvement in MBF, leading to
a significant increase in MVR. These results are consistent
with those reported by Stadlbauer et al. [24].
In this study, we used an infusion rate of 0.04 U/kg/
min which is much lower than the dose of vasopressin
commonly used (i.e., 0.04 U/min) considering the rat
median weight (i.e., 325 g). High amounts of vasopressin
infusion were reported to be associated with detrimental
side effects [8, 25].
Capillary permeability increases when there is damage
or death of the endothelial cells and change in the inter-
cellular space, rendering the endothelial cells and base-
ment membrane less effective barriers to large molecules.
Damage to the endothelial cells is initiated by an
ischemia-reperfusion phenomenon, which promotes neu-
trophil activation and the release of proteases, oxygen rad-
icals, and other toxic substances [26–28]. Various organs
reveal different sensitivities to hypoxic-ischemic insult
resulting in increased or decreased diffusion of macromol-
ecules from the circulation into the interstitial space [29].
The initial phase of HS resuscitation comprises infusions
of fluids, often leading to rapid tissue swelling, that may
result in organ damage and dysfunction due to fluid and
protein extravasation [30].
In the current study, HS alone was able to determine
significant capillary leakage in the lung, ileum, and kidney,
which was established by the albumin-bound EB extrava-
sation in these organ tissues. Schumacher et al. also dem-
onstrated significant capillary leakage in the lung and
kidney in a similar HS experimental model [16]. In the
vasopressin group, an increased capillary leakage, mark-
edly higher than that in the group resuscitated with RL
plus blood, was observed in the lung. This finding was also
associated with a significant decrease in pO2 in this group.
According to the equation by Starling, increase in
vasopressin-induced capillary hydrostatic pressure deter-




Fig. 5 Capillary leakage in the lung (a), ileum (b), and kidney (c). Data
are expressed as mean ± SD of micrograms of Evans blue (EB) per gram
of dried tissue. HS, hemorrhagic shock; RL, resuscitation with Ringer’s
lactate; RLB, resuscitation with Ringer’s lactate and blood; AVP,
resuscitation with Ringer’s lactate and vasopressin infusion. a *p< 0.05
HS and RL vs S; #p< 0.05 RLB vs HS and RL; §p< 0.01 AVP vs HS and RL
and p< 0.05 AVP vs RLB; b *p< 0.05 HS and RL vs S; #p< 0.05 RLB vs HS
and RL; §p< 0.05 AVP vs HS and RL and p< 0.01 AVP vs RLB; c *p< 0.05
HS and RL vs S; #p< 0.05 RLB and AVP vs HS and RL
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a drop in plasma oncotic pressure owing to dilution of
circulatory volume, protein loss, and extravascular leakage
[30]. This is consistent with the results of the study by
Stadlbauer et al., which asserts that one of the effects of
vasopressin may be the shifting of blood away from below
the diaphragm to above it with increased extravascular
lung water [24].
Contrarily, Lee et al. [31] showed that the vasopressin
group had lower pulmonary edema than the group
resuscitated with RL and blood; however, the different
experimental protocol (pulmonary edema formation was
investigated 3 days after HS) used may account for this
inconsistency. Feinstein et al., in an animal model of
thoracic trauma and HS, showed that the early use of
vasopressin improves lung function when compared to
animals treated with fluids only [32]. This finding is not
in conflict with our data because in that study, the ani-
mals were mechanically ventilated, whereas the rats in
our study maintained spontaneous breathing throughout
the experimental procedure. Actually, the positive pres-
sure may have exerted a reduction in alveolar edema.
Interestingly, resuscitation with RLB was associated
with increased capillary leakage in the ileum, whereas
vasopressin use was accompanied by a decrease in leak-
age. However, the consistent vasoconstriction of mesen-
teric blood flow induced by vasopressin observed in our
study may impair the gut mucosal perfusion. Stadlbauer
et al. showed that infusion of vasopressin was followed
by transient non-bloody diarrhea 3 h after stabilization,
suggesting a potential gut ischemia [33].
In the present study, a similar increase in capillary leak-
age was noted in the kidney in the RLB and vasopressin
groups. In the extracerebral tissues, vasopressin works
primarily on the arterioles with less constriction on the
coronary and renal vessels, thereby having vasodilatory
effects on cerebral and pulmonary flow [34]. Besides,
preservation of renal blood flow by vasopressin has been
demonstrated in an experimental model of HS [35, 36].
In experimental models, early administration of vaso-
pressors was able to restore a quasi-normal hemodynamic
status by mobilizing non-constraint venous blood volume
and thus normalizing hemodynamic parameters (arterial
blood pressure, cardiac output, and pulse pressure varia-
tions) [37]. This masked hypovolemia was associated with
deleterious effects of vasopressor use in experimental
hemorrhage models, due to the worsening of tissue hypo-
perfusion leading to metabolic disturbances, such as meta-
bolic acidosis [38, 39].
Interestingly, in the present study, we found signifi-
cantly higher base deficit and lactate levels in the vaso-
pressin group when compared to the other groups. This
finding recognizes a multifactorial etiology. Recently, in
a swine model of HS, Soller et al. [40] found that lactate
is a predictor of mortality with an area under the ROC
curve of 0.87. Besides, several studies have already iden-
tified worsening base deficit as an indicator of increased
transfusion requirement [41, 42]. Furthermore, base
deficit has been associated with increased mortality and
intensive care unit and in-hospital lengths of stay, with a
higher incidence of shock-related complications such as
acute respiratory distress syndrome, renal failure, hemo-
coagulative disorders, and multiorgan failure [43]. Moni-
toring of base deficit has also been suggested as an
indicator and a monitoring parameter for the success of
resuscitation efforts [44].
On a final note, our controlled hemorrhage and resus-
citation model does a good job of mimicking clinical
reality, but we should make a strong case for translation
of this research to humans. According to a very recent
review [45], in HS, a successful resuscitation requires to
stanch all sources of hemorrhage and rapidly restore the
intravascular volume by a resuscitation approach that
emphasizes the use of all blood products. However, vaso-
pressin supplementation is considered a therapy that
may reduce blood product and fluid requirements in
patients with HS [45, 46].
Strengths and limitations of the study
To the best of our knowledge, this is the first study in-
vestigating the early effects of vasopressin on metabolic
and hemodynamic parameters and endothelium perme-
ability by measuring the capillary leakage in different
organ tissues compared to those of other resuscitation
strategies in a HS model.
This study has several limitations. First, we used a
controlled hemorrhage model, not the same as free
hemorrhage following injury. Second, we used a relatively
small dose of vasopressin, less than is generally used in
humans. Also, the effects of vasopressin infusion were
observed only for a short-term period. Thus, the true clin-
ical applicability is perhaps difficult to precise. Finally, we
used capillary leakage as a marker for endothelium dys-
function in the experimental model; however, capillary
leakage is not a “synonym” of organ dysfunction or dam-
age. Indeed, histopathological and immunohistochemical
analyses should be performed to evaluate the effects of
vasopressin on organ damage or dysfunction.
Conclusions
Vasopressin was proposed as a vasoactive drug for
provisional hemodynamic optimization in the early
phase of HS resuscitation. In this study, vasopressin
restored the MAP while causing a significant decrease in
the mesenteric blood flow. In the vasopressin group, in-
creased capillary leakage was observed in the lung,
which was markedly higher than that in the group resus-
citated with RL plus blood; this increase was also associ-
ated with a significant decrease in pO2. Conversely, a
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decrease in capillary leakage was observed with vaso-
pressin in the ileum. Lastly, we found that vasopressin
use was associated with significantly higher base deficit
and lactate levels when compared to the other groups.
In conclusion, vasopressin may be used as a bridge to
definitive treatment for HS, but the overall findings of
this experimental study focus on the possible critical side
effects of vasopressin on metabolic parameters and
endothelium permeability. Based on the available informa-
tion and due to the small number of human studies on
this issue, it is still controversial whether the use of
vasopressin may positively impact on outcomes in
uncontrolled bleeding patients. Thus, randomized
controlled trials are needed to clarify the effects of
vasopressin in HS [39, 47].
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